HIKAL Financial Statement Analysis
|
||
The Revenues of HIKAL have decreased by -11.79% YoY .
The Earnings Per Share (EPS) of HIKAL has decreased by -11.32 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
HIKAL Last 5 Annual Financial Results
[BOM: 524735|NSE : HIKAL]
Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹1,785 Cr | ₹2,023 Cr | ₹1,943 Cr | ₹1,720 Cr | ₹1,507 Cr |
Expenses | ₹1,518 Cr | ₹1,766 Cr | ₹1,602 Cr | ₹1,398 Cr | ₹1,234 Cr |
Operating Profit (Excl OI) | ₹267 Cr | ₹257 Cr | ₹341 Cr | ₹323 Cr | ₹273 Cr |
Other Income | ₹2.45 Cr | ₹5.41 Cr | ₹4.89 Cr | ₹4.98 Cr | ₹3.70 Cr |
Interest | ₹56 Cr | ₹48 Cr | ₹31 Cr | ₹36 Cr | ₹52 Cr |
Depreciation | ₹118 Cr | ₹109 Cr | ₹96 Cr | ₹85 Cr | ₹82 Cr |
Profit Before Tax | ₹96 Cr | ₹105 Cr | ₹219 Cr | ₹206 Cr | ₹127 Cr |
Profit After Tax | ₹70 Cr | ₹78 Cr | ₹160 Cr | ₹133 Cr | ₹84 Cr |
Consolidated Net Profit | ₹70 Cr | ₹78 Cr | ₹160 Cr | ₹133 Cr | ₹84 Cr |
Earnings Per Share (Rs) | ₹5.64 | ₹6.36 | ₹13.02 | ₹10.80 | ₹6.85 |
PAT Margin (%) | 3.90 | 3.87 | 8.26 | 7.74 | 5.60 |
ROE(%) | 6.00 | 7.12 | 16.04 | 15.22 | 10.74 |
ROCE(%) | 7.82 | 8.47 | 15.21 | 16.15 | 12.44 |
Total Debt/Equity(x) | 0.69 | 0.66 | 0.63 | 0.65 | 0.79 |
Key Financials |
||
Market Cap | : | ₹ 4,279.7 Cr |
Revenue (TTM) | : | ₹ 1,803.4 Cr |
Net Profit(TTM) | : | ₹ 67.8 Cr |
EPS (TTM) | : | ₹ 5.5 |
P/E (TTM) | : | 63.1 |
Industry Peers & Returns | 1W | 1M | 1Y |
HIKAL | 5.1% | 7.6% | 15.1% |
SUN PHARMACEUTICAL INDUSTRIES | 0.4% | 5.1% | 64.6% |
CIPLA | -2.1% | 3.7% | 30.8% |
DR REDDYS LABORATORIES | -2.9% | -3.7% | 20.1% |
ZYDUS LIFESCIENCES | -1% | -13.6% | 81.7% |
DIVIS LABORATORIES | 2.1% | 3.9% | 42.8% |
HIKAL Revenues
[BOM: 524735|NSE : HIKAL]
Y-o-Y | -11.79 % |
5 Yr CAGR | 4.31 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹1,785 Cr | -11.79 | |
Mar2023 | ₹2,023 Cr | 4.13 | |
Mar2022 | ₹1,943 Cr | 12.92 | |
Mar2021 | ₹1,720 Cr | 14.14 | |
Mar2020 | ₹1,507 Cr | - |
HIKAL Operating Profit
[BOM: 524735|NSE : HIKAL]
Y-o-Y | 3.88 % |
5 Yr CAGR | -0.57 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹267 Cr | 3.88 | |
Mar2023 | ₹257 Cr | -24.51 | |
Mar2022 | ₹341 Cr | 5.47 | |
Mar2021 | ₹323 Cr | 18.20 | |
Mar2020 | ₹273 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 17.70 % |
5 Yr CAGR | -4.68 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 14.96% | 17.70 | |
Mar2023 | 12.71% | -27.50 | |
Mar2022 | 17.53% | -6.61 | |
Mar2021 | 18.77% | 3.59 | |
Mar2020 | 18.12% | - |
HIKAL Profit After Tax
[BOM: 524735|NSE : HIKAL]
Y-o-Y | -11.20 % |
5 Yr CAGR | -4.71 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹70 Cr | -11.20 | |
Mar2023 | ₹78 Cr | -51.16 | |
Mar2022 | ₹160 Cr | 20.55 | |
Mar2021 | ₹133 Cr | 57.68 | |
Mar2020 | ₹84 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 0.78 % |
5 Yr CAGR | -8.65 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 3.9 % | 0.78 | |
Mar2023 | 3.87 % | -53.15 | |
Mar2022 | 8.26 % | 6.72 | |
Mar2021 | 7.74 % | 38.21 | |
Mar2020 | 5.6 % | - |
HIKAL Earnings Per Share (EPS)
[BOM: 524735|NSE : HIKAL]
Y-o-Y | -11.32 % |
5 Yr CAGR | -4.74 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹5.64 | -11.32 | |
Mar2023 | ₹6.36 | -51.15 | |
Mar2022 | ₹13 | 20.56 | |
Mar2021 | ₹11 | 57.66 | |
Mar2020 | ₹6.85 | - |
HIKAL Return on Capital Employed (ROCE)
[BOM: 524735|NSE : HIKAL]
Y-o-Y | -7.67 % |
5 Yr CAGR | -10.96 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 7.82% | -7.67 | |
Mar2023 | 8.47% | -44.31 | |
Mar2022 | 15.21% | -5.82 | |
Mar2021 | 16.15% | 29.82 | |
Mar2020 | 12.44% | - |
HIKAL Share Price vs Sensex
Current Share Price | : | ₹347.1 |
Current MarketCap | : | ₹ 4,279.7 Cr |
Updated EOD on | : | Sep 06,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | 5.1% |
7.6% |
15.1% |
SENSEX | -1.4% |
3.3% |
25.2% |
HIKAL related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 0.7% | 8.6% | 55.8% |
S&P BSE SMALL CAP | -0.1% | 7.6% | 50.7% |
S&P BSE MIDSMALLCAP | -0.6% | 7% | 53.1% |
S&P BSE ALLCAP | -1.1% | 4.7% | 39.1% |
You may also like the below Video Courses
FAQ about HIKAL Financials
How the annual revenues of HIKAL have changed ?
The Revenues of HIKAL have decreased by -11.79% YoY .
How the Earnings per Share (EPS) of HIKAL have changed?
The Earnings Per Share (EPS) of HIKAL has decreased by -11.32 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs